NCT01970137View on ClinicalTrials.gov

A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

October 31, 2014

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373, High dose

DRUG

KPS-0373, Low dose

Trial Locations (1)

Unknown

Tokyo and Other Japanese Cities

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01970137 - A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) | Biotech Hunter | Biotech Hunter